Dron Gauchan is an Oncology physician affiliated with CHI Health St. Francis. OpenAlex indexes 34 publications with 225 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11795 Education St Ste 232
Auburn, CA 956022469
Telephone
530-886-6587Provider last certified this registry record 23 Mar 2021.
Industry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20256 payments
- Amgen Inc.Program year20252 payments
- HISTOSONICS, INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
29.1%Aromatase Inhibitor14.5%Anastrozole78%Letrozole17%Exemestane5%Part D<11 patientsCytochrome P450 17A1 Inhibitor5.1%Abiraterone Acetate100%Part D≥13 patients+ 3 more classes in this area
Metabolism & gastrointestinal
22.2%Corticosteroid9.8%Prednisone100%Part D≥49 patientsSerotonin-3 Receptor Antagonist9.2%Ondansetron Hcl89%Ondansetron Odt12%Part D≥83 patients+ 2 more classes in this area
Nervous system
18.6%Phenothiazine10.6%Prochlorperazine Maleate100%Part D≥102 patientsGabapentinoids2.6%Gabapentin70%Pregabalin30%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Targeted Therapy
Journal of Clinical Oncology
2018 - Potential cost savings by dose down-rounding of monoclonal antibodies in a community cancer center
Journal of Oncology Pharmacy Practice
2017 - Neoadjuvant Chemotherapy or Primary Debulking Surgery for Stage IIIC Ovarian Cancer
Journal of Clinical Oncology
2017
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”